Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The financial performance shows some positive aspects, such as increased operating capital generation and a healthy cash capital position. However, significant concerns include net outflows in retirement plans, market volatility impacting financial stability, and regulatory transition risks. The Q&A session highlighted uncertainty in capital return policies and unclear responses on mortality trends and hedging costs. The planned share buyback is positive but overshadowed by broader financial and strategic concerns, leading to a negative sentiment.
Operating Capital Generation €267 million, an increase of 4% year-on-year, driven by business growth in most strategic assets, partly offset by unfavorable mortality experience in U.S. financial assets.
Free Cash Flow €34 million, reflecting a remittance from a joint venture in international and €19 million of proceeds from ASR share buyback program.
Cash Capital at Holding €1.6 billion, indicating a very healthy capital position at the end of March.
Gross Financial Leverage €5.1 billion, consistent with target level.
U.S. RBC Ratio 436%, a decrease of 7 percentage points compared to the end of December, impacted by market movements and one-time items.
Scottish Equitable Solvency Ratio 189%, an increase of 3 percentage points driven by operating capital generation.
Share Buybacks €102 million returned to shareholders, with a planned new share buyback program of €200 million set to commence in July.
New Life Sales: In International, we recorded an 11% year-over-year increase in new life sales after some slower quarters last year.
RILA Product Growth: Within Protection Solutions, we continue to see growth in the RILA product, thanks to further improvements of our wholesale distribution productivity.
Agent Base Growth: In the U.S., World Financial Group continues to grow its agent base, with the number of licensed agents increasing by 16% to 88,000 compared with the same quarter of last year.
Market Share Increase: Transamerica’s market share in WFG increased to 66% from higher agent productivity in selling Transamerica’s products.
New Representative Office: TLB is setting out on a path for profitable growth with the opening of a new representative office in Dubai.
Operating Capital Generation: Operating capital generation before holding and funding expenses amounted to €267 million, driven by business growth in most strategic assets.
Cash Capital at Holding: Cash capital at holding stood at a very healthy €1.6 billion at the end of March.
Share Buyback Program: A planned new share buyback program of €200 million is set to commence at the beginning of July and is expected to conclude before the end of the year.
Solvency Ratio Update: Aegon will apply an aggregation approach to calculate its group solvency ratio under the Bermuda solvency framework after the transition period.
Unfavorable Mortality Experience: The company experienced unfavorable mortality claims, particularly in Universal Life, which impacted operating capital generation. This was partly expected due to seasonality.
Midsized Retirement Plans Outflows: Aegon recorded net outflows of $283 million in midsized retirement plans due to lower gross deposits and elevated participant withdrawals.
Market Volatility Impact: The financial markets experienced significant volatility in April, which negatively affected the U.S. RBC ratio and is expected to have a single-digit negative impact in the second quarter.
Regulatory Transition Risks: Aegon is undergoing a transition in group supervision from the Dutch Central Bank to the Bermuda Monetary Authority (BMA), which could pose risks until the transition period ends in December 2027.
Capital Instrument Eligibility Changes: Changes in the eligibility of capital instruments under the Bermuda solvency framework could lead to a 6 percentage point decrease in the group solvency ratio, affecting financial stability.
Operating Capital Generation: Operating capital generation before holding and funding expenses amounted to €267 million, driven by business growth in most strategic assets.
Share Buyback Program: A planned new share buyback program of €200 million is set to commence at the beginning of July and is expected to conclude before the end of the year.
Agent Growth: The number of licensed agents in World Financial Group increased by 16% to 88,000 compared with the same quarter of last year.
New Life Sales: Internationally, there was an 11% year-over-year increase in new life sales.
Market Position: Transamerica established itself as a top 10 player in the RILA product sales in the U.S. market.
2025 Financial Targets: Aegon expects to achieve all group financial targets for 2025 as set out at the last Capital Markets Day in 2023.
Operating Capital Generation Target: Aegon confirms a target of around €1.2 billion operating capital generation for 2025.
Quarterly OCG Run Rate: A quarterly OCG run rate for the Americas is expected to be between $200 million to $240 million for the remainder of the year.
Cash Capital at Holding: Aegon plans to reduce cash capital at holding to around €1 billion by the end of 2026.
Share Buyback Program: Aegon announced a planned new share buyback program of €200 million, set to commence at the beginning of July 2025 and expected to conclude before the end of the year. This follows the current €150 million program.
Capital Returned to Shareholders: Aegon returned €102 million of capital to shareholders through share buybacks, part of which will be used for share-based compensation plans.
The earnings call reflects a solid financial performance with increased free cash flow and interim dividends, despite some negative aspects like decreased valuation equity per share. The company announced a share buyback program, which is typically seen positively. The Q&A did not reveal significant concerns, and management's confidence in achieving targets further supports a positive outlook. The market cap is not available, but the overall sentiment leans towards a positive reaction, likely resulting in a stock price increase of 2% to 8%.
The financial performance shows some positive aspects, such as increased operating capital generation and a healthy cash capital position. However, significant concerns include net outflows in retirement plans, market volatility impacting financial stability, and regulatory transition risks. The Q&A session highlighted uncertainty in capital return policies and unclear responses on mortality trends and hedging costs. The planned share buyback is positive but overshadowed by broader financial and strategic concerns, leading to a negative sentiment.
The earnings call showed mixed results: strong performance in asset management and protection solutions, but a decrease in the US operating result. The solvency ratio decreased, yet a share buyback is positive. The Q&A highlighted uncertainties in management actions and remittances, with no major concerns. Overall, the financials and guidance are balanced, leading to a neutral sentiment.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.